Support Clinical Decision Articles & Analysis
36 news found
Effective October 3rd, 2022, Laurie Smith has joined as Vice President of Product Strategy – Clinical Trial Matching. Laurie will be primarily focused on enhancing Inspirata’s suite of clinical trial matching solutions. ...
Ariana Pharma, the leading Al-driven precision medicine company, has announced the first comprehensive blarcamesine pathway analysis impact using extensive data from the ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia (PDD) clinical study. Initial results were presented by Ariana Pharma at the Alzheimer’s Association International Conference (AAIC 2022) in San Diego, in ...
We are starting to see the use of AI in clinical practice and our goal is to accelerate this by supporting the most promising innovators and playing an active role in the Canadian health tech ...
Combining capabilities to develop breakthrough technologies for transforming surgery. Hospitals and Surgery Centers face many challenges in surgery as they work to recover from COVID. Directors of Perioperative Services, Surgeons, OR Staff and OR managers are facing high levels of stress with maintaining quality patient care, increasing surgical case volume from backlogs, while at the same time ...
Ariana Pharma, the leading eXplainable Artificial Intelligence (xAI) drug development company, announce the appointments of Dr. Marion Soto as Vice President, Business Development and Bertrand Lellouche as Chief Financial Officer. The financial and commercial experience of Marion and Bertrand will further drive Ariana’s accelerated growth. Marion and Bertrand will be bringing their ...
Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). ...
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research Reports Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today ...
Ariana Pharma and OmiCure announce their collaboration with the renowned CLB Cancer Center to apply OmiCure and Ariana Artificial Intelligence (AI) capabilities to find more efficient treatments for cancer patients. The data were communicated at ASCO 2022 last week and showed that Artificial Intelligence RNA-based therapeutic recommendations have the potential to expand personalized cancer ...
Ariana Pharma, the eXplainable Artificial Intelligence clinical development Company, announced today the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia (PDD) study at the AD/PD 2022 International Conference. MDS-UPDRS Total score improved significantly for patients treated with ANAVEX®2-73 high oral once-daily dose compared to ...
The second proof-of-concept study, published in CTS: Clinical and Translational Science, investigated autoimmunity associated with immunotherapies. ...
Jean, a veteran from both Medtronic and Sensionics, has focused on recruiting top talent to the sales and clinical support team and has added eight new territory managers/clinical support reps to the team to support the strong growth in accounts. ...
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Ariana Pharma (Cambridge, MA and Paris, France) today announced an artificial intelligence-driven, precision medicine collaboration. This collaboration is expected to identify biomarkers of response to refine patient selection to guide and accelerate the clinical development of Cyclerion’s investigational therapeutics for neurological and ...
AI has matured since the early 2000s, and is now poised to be a leading clinical decision support tool, assisting radiologists and other clinicians in the global fight to improve cancer survival rates." ...
These procedures included general surgery, gynecology, urology, colorectal, pediatric, and bariatric surgical cases. Clinical Validation During 2021, there were 21 peer-reviewed clinical papers published providing further support for the clinical utility of the Senhance System across a variety of surgical specialties. ...
’s PINC AI™, an advanced technology and services platform that provides artificial intelligence-enabled clinical performance improvement technologies, to support patient access to Galleri®, GRAIL’s groundbreaking multi-cancer early detection blood test. Under the partnership, Premier’s PINC AI will augment its AI-enabled ...
Investing in key hires to both the Board and senior management positions is crucial to supporting the commercial roll-out of the Company’s NeuroMotor PenTM, ensuring there is a breadth of knowledge, corporate collaboration experience and sales expertise. Dr Wood-Gush has a clinical background in ophthalmology and neurosurgery, and has over 20 years of ...
The study intended to evaluate the gain in specificity using opto-acoustic ultrasound images and an AI-based decision support tool verses ultrasound alone. The study found that OA/US, when used with a decision support tool, has statistically significant better specificity compared to conventional ultrasound alone. ...
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today introduced PeriWatch Vigilance® Mobile, a full-function browser-based solution providing access to its early warning system (EWS) and clinical decision support tool. By providing remote access to the full range of conditions ...
The combination is unprecedented in bringing electronic medical records, genomic data, and medical image data into one integrated network and set of AI-enabled workflows that enable leading software-as-a-service (SaaS) clinical research and clinical decision support applications. The integration creates the industry’s first ...
Having a dedicated, technology-enabled clinical team available to monitor and assist can only help reduce risk and improve outcomes for all.” As a result of the successful trial, the SCL Health clinical leadership team has received system-wide perinatal executive support to expand their OB Hub vision and provide coverage across the eight ...